Continuous infusion of meropenem-vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance.

"Declarations Conflict of interestRL has received consulting fees from MSD, payment or honoraria for lectures, presentations, speakers’ bureaus or educational events from BioMérieux, MSD, Pfizer and Shionogi, and support for attending meetings and/or travel from BioMérieux, MSD, Pfizer and Shionogi. AS has received consulting fees from Besins Healthcare and Karo Pharma, support for attending meetings and/or travel from Pfizer and MSD, and participates free of charge on advisory boards of Biofilm Control and CTX Laboratory. All other authors declare that they have no conflict of interest. Ethical approvalEthical approval was not required by the local ethics committee for the case report. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. Consent to participateThe patient provided written informed consent to participate in the study. Consent to publishThe patient provided written informed consent for the publication of this report. Conflict of interest RL has received consulting fees from MSD, payment or honoraria for lectures, presentations, speakers’ bureaus or educational events from BioMérieux, MSD, Pfizer and Shionogi, and support for attending meetings and/or travel from BioMérieux, MSD, Pfizer and Shionogi. AS has received consulting fees from Besins Healthcare and Karo Pharma, support for attending meetings and/or travel from Pfizer and MSD, and participates free of charge on advisory boards of Biofilm Control and CTX Laboratory. All other authors declare that they have no conflict of interest."

"Funding No funds, Grants, or other support was received."